Skip to content

Lennox-Gastaut Syndrome Reference

Lennox-Gastaut syndrome (LGS) was a childhood-onset developmental and epileptic encephalopathy characterized by drug-resistant epilepsy, multiple seizure types, characteristic electroencephalogram patterns, and developmental or intellectual impairment. It often evolved from an earlier epilepsy or underlying neurological condition rather than appearing fully formed with the first seizure.

Overview

LGS involved distributed brain networks rather than one uniform lesion or one universal cause. Structural brain differences were common, but genetic, metabolic, infectious, immune, and unknown causes also occurred. A child could have developmental differences before LGS emerged, and ongoing epileptic activity could add further developmental stagnation or regression.

The syndrome usually began between eighteen months and eight years of age, with a peak between three and five. Later recognition was possible when earlier seizures had been classified more broadly, historical EEG records were incomplete, or the characteristic seizure and EEG pattern had not yet been assembled into one diagnosis.

LGS was not interchangeable with any epilepsy that caused frequent seizures. The diagnosis required a specific combination of seizure types, EEG findings, drug resistance, and developmental or intellectual impairment.

Seizures and Presentation

Tonic seizures, particularly during sleep, were central to LGS. During a tonic seizure, muscles stiffened suddenly; the event could be subtle during sleep or could cause a fall when the person was upright. The International League Against Epilepsy’s diagnostic criteria also required at least one additional seizure type, such as atypical absence, atonic, myoclonic, focal impaired-awareness, generalized tonic-clonic, epileptic spasms, or nonconvulsive status epilepticus.

The term ‘’drop attack’’ described a sudden fall rather than one single seizure mechanism. Atonic loss of muscle tone could cause a drop, but tonic stiffening and other seizure types could also produce abrupt falls. Repeated drop attacks created substantial risk of facial, dental, head, and limb injury.

Atypical absence seizures could involve a less abrupt and less complete interruption of awareness than typical absence seizures. Changes might include staring, slowed or interrupted response, reduced movement, or subtle changes in muscle tone. Focal and generalized convulsive seizures could coexist with the generalized seizure types.

Seizures could cluster, and LGS carried risk of convulsive or nonconvulsive status epilepticus. An individual rescue plan identified which events required rescue medication, emergency services, or hospital care. Seizure first aid and escalation followed that plan rather than a single routine applied to every event.

Development, Cognition, and Behavior

Developmental or intellectual impairment was part of the current diagnostic framework, but its timing and degree varied. Some children already had substantial developmental disabilities before LGS emerged. Others showed slowed development, loss of skills, or increasing support needs after seizures became frequent. Communication, attention, processing speed, behavior, sleep, and school access could all be affected by the underlying cause, the seizures, treatment effects, or a combination of those factors.

The diagnosis did not determine a person’s personality, emotional depth, capacity for attachment, artistic interests, or ability to make choices. Support for communication and decision-making remained necessary even when speech or standardized cognitive testing underestimated understanding.

Diagnosis and Differential Diagnosis

Diagnosis combined clinical history with electroencephalography. Under the International League Against Epilepsy criteria current in 2024, the mandatory EEG findings were generalized slow spike-and-wave activity below 2.5 hertz and generalized paroxysmal fast activity during sleep. Slow spike-and-wave activity could become less visible by adulthood, which made historical EEG records important during later reassessment.

Magnetic resonance imaging was usually performed to look for a structural cause, although no single MRI finding established LGS. Genetic, metabolic, infectious, or immune testing depended on history, examination, imaging, and the age at onset. Video recordings and prolonged or sleep EEG could help classify subtle nocturnal or nonconvulsive events.

Differential diagnosis included epilepsy with myoclonic-atonic seizures, developmental or epileptic encephalopathy with spike-wave activation in sleep, Dravet syndrome, focal epilepsy with rapid bilateral synchronization, and other developmental and epileptic encephalopathies. Reassessment was important when the seizure pattern or EEG changed over time.

Treatment and Management

LGS usually remained drug resistant, so treatment aimed to reduce seizure frequency and severity, prevent prolonged events and injuries, preserve alertness and participation, and limit adverse effects. Complete seizure freedom was possible for some people but was not a safe assumption for an individual course.

Specialist care commonly involved an adult or pediatric neurologist with epilepsy expertise. Medication selection was individualized. Options used for seizures associated with LGS included sodium valproate, lamotrigine, clobazam, rufinamide, topiramate, felbamate, cannabidiol, and fenfluramine. Their indications, age limits, interactions, monitoring requirements, and adverse effects differed. No fixed sequence or maximum number of medications applied to every person.

Dietary therapy, including a medically supervised ketogenic diet, could be considered when medication did not provide adequate control. Nutrition, swallowing, gastrointestinal motility, growth, and medication formulation affected whether a dietary approach was safe or practical.

Vagus nerve stimulation and selected epilepsy surgery could be considered after specialist evaluation. Corpus callosotomy could reduce injurious drop attacks in some people, while resective surgery depended on identifying an appropriate structural or focal target. These interventions could reduce seizures without guaranteeing seizure freedom.

Rescue medication and emergency planning were separate from daily treatment. Families, schools, residential programs, and support workers needed current instructions describing the person’s seizure types, usual recovery, prescribed rescue medication, and emergency thresholds.

Course and Complications

LGS usually persisted into adulthood, although the visible seizure pattern could change. Atonic seizures often became less prominent, tonic seizures could remain most apparent during sleep, and the classic slow spike-and-wave EEG pattern could fade. Developmental, communication, behavioral, mobility, and daily-living support needs could continue even when one seizure type improved.

Complications included injuries from falls, aspiration, prolonged seizures, hospital and intensive-care admissions, medication toxicity, reduced alertness, sleep disruption, and sudden unexpected death in epilepsy. Population-level risk did not predict one person’s exact outcome.

Daily Life and Accessibility

Seizure access planning depended on the person’s actual events and environment. Protective headgear, wheelchair positioning, postural supports, floor-level sleeping arrangements, supervision near water, and modifications to bathing or transfer routines could reduce injury for some people. Any harness or positioning system required individualized fitting, regular reassessment, and a balance between safety, comfort, movement, skin protection, breathing, and voluntary access.

Sleep loss, illness, fever, missed or poorly absorbed medication, and individual triggers could increase seizures, but photosensitivity, noise sensitivity, heat sensitivity, and emotional stress were not universal LGS features. A personal seizure record was more useful than assuming that every common epilepsy trigger applied.

Consumer wearables could provide sleep, movement, heart-rate, temperature, or recovery trends, but an ordinary wellness ring was not a substitute for seizure observation, prescribed monitoring, EEG, or a rescue plan. Trend data could be recorded alongside witnessed events without treating the wearable as a seizure detector.

Communication access remained part of seizure care. A person might need extra time, familiar communication partners, AAC, interpretation, or low-demand recovery after a seizure. Caregivers and clinicians still addressed the person directly and preserved consent and choice wherever possible.

Associated Characters

Minjae Lee

Main article: Minjae Lee

Minjae experienced drug-resistant epilepsy from childhood, with absence, focal, tonic-clonic, and drop seizures as well as episodes of status epilepticus. His wheelchair used a full postural harness to reduce injury when a drop seizure caused his trunk or head to fall suddenly.

During the November 14–20, 2032, Rome International Piano Competition, Minjae had an absence seizure during a photo opportunity. Jacob recognized the event, stopped the photographer from rushing him, waited without touching him, and greeted his return with, “There you are.” After the family returned to Tianjin, Minjae had increased nocturnal seizures and profound fatigue. A later status episode lasted nearly thirty minutes and became part of the crisis that brought Logan Weston into the family’s care network.

Logan recognized the LGS pattern during remote review of Minjae’s childhood seizure history, developmental history, and post-Rome escalation. Johns Hopkins later confirmed the diagnosis after the Lee family’s lengthy approvals and preparation process and their early-2034 relocation to Baltimore. Before that confirmation, Minjae’s records described childhood drug-resistant epilepsy without the LGS label.

Minjae’s severe chronic fatigue, spastic cerebral palsy, POTS, gastroparesis, autism, and developmental disability affected seizure recovery, nutrition, communication, positioning, and the amount of activity he could sustain. He did not have a separate ME/CFS diagnosis.

Caleb Ross

Main article: Caleb Ross

Caleb lived with LGS and multiple seizure types, including absence and drop seizures, alongside hypotonic cerebral palsy. His treatment included multiple antiseizure medications and an implanted vagus nerve stimulator. Jess Ross carried its magnet and taught familiar caregivers its use within his seizure plan. He also required ongoing monitoring, positioning support, and communication access. After he and Jess moved from Portland to Baltimore in March 2038, he slept better and experienced fewer seizures; the improvement did not erase the diagnosis or establish one universal cause for the change.

Caleb and Minjae recognized aspects of seizure care in one another’s lives. Their shared diagnosis helped their families coordinate access without making the two young men’s seizure patterns, communication, or support needs identical.

Mateo Garcia

Main article: Mateo Garcia

Luis and emergency staff identified LGS in Mateo’s medical history during his childhood seizure-cluster admission. His refractory epilepsy coexisted with mild intellectual disability, developmental coordination disorder, ADHD, and disabling fatigue. Around twelve, repeated tonic-clonic seizures continued despite prescribed rescue treatment and required emergency transport and hospital monitoring. Mateo’s presentation and support needs differed from Caleb’s and Minjae’s; he spoke English and Spanish, attended school with inclusion and resource-room support, and used a power wheelchair in public.

Historical Context

William G. Lennox and Henri Gastaut’s mid-twentieth-century work helped define the electroclinical pattern, and the combined name ‘’Lennox-Gastaut syndrome’’ entered use during the 1960s.

Later classification moved away from defining LGS through a loose triad alone. Modern criteria distinguished mandatory seizure and EEG features, recognized that the syndrome could evolve from an earlier epilepsy, and treated it as a developmental and epileptic encephalopathy. Treatment options expanded through additional antiseizure medications, dietary therapy, neurostimulation, and epilepsy surgery, but the condition remained difficult to control.

Sources

Medical Conditions Neurological Conditions Chronic Conditions